Hypoxanthine transport and metabolism in the central nervous system.
The mechanisms by which hypoxanthine, the principal purine in plasma and CSF, enters and leaves rabbit brain, choroid plexus, and CSF were investigated in the isolated choroid plexus in vitro and by injecting [14C]hypoxanthine intraventricularly and [3H]hypoxanthine intravenously. The isolated choroid plexus accumulated and extensively metabolized [14C]hypoxanthine; however, 14C was readily released from choroid plexus principally as [14C]-hypoxanthine. After infusion of [3H]hypoxanthine intravenously, [3H]hypoxanthine entered CSF and brain slowly and was converted in brain to nucleotides. Fewer than 5% of the acid-soluble purine nucleotides in brain entered rabbit brain from plasma hypoxanthine (and inosine) per 24 h. After intraventricular injection of [14C]hypoxanthine, the [14C]hypoxanthine was cleared from the CSF into the blood or accumulated by brain and largely converted into 14C-nucleotides. Little [14C]xanthine and no [14C]uric acid or allantoin were formed. These studies show that brain, unlike most other tissues, rapidly recycles hypoxanthine and converts it into purine nucleotides, and not unsalvageable purines.
D000818:Animals; D001692:Biological Transport; D001921:Brain / Q000378:metabolism; D002490:Central Nervous System / Q000378:metabolism*; D002831:Choroid Plexus / Q000378:metabolism; D019271:Hypoxanthine; D007042:Hypoxanthines / Q000097:blood / Q000134:cerebrospinal fluid / Q000493:pharmacokinetics*; D066298:In Vitro Techniques; D007276:Injections, Intraventricular; D008353:Mannitol / Q000134:cerebrospinal fluid / Q000493:pharmacokinetics; D009994:Osmolar Concentration; D011817:Rabbits
D007042:Hypoxanthines; D019271:Hypoxanthine; D008353:Mannitol